Clinical Trial Update: Covid-19 in Hematological Malignancies

View source ↗

Summary

This clinical trial update notes an ongoing study evaluating COVID-19 infection in patients with hematologic malignancies, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Snippet

Sponsor: Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne | Conditions: COVID-19 Infection in Hematological Malignancies Patients | Status: RECRUITING